EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effects of Febuxostat Therapy on Circulating Adipokine Profiles in Patients with Overweight or Obesity and Asymptomatic Hyperuricemia: A Randomized Controlled Study

Meijuan Dong, Zhaohui Cui, Yuanyuan Liu, Yanlong Bu, Kun An, Li Mao

Obesity Facts · 2024

DOI: 10.1159/000540701 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Obesity Facts, 2024. Verfasst von Meijuan Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, China. Hauptthemen laut MEDLINE: Febuxostat, Hyperuricemia, Adipokines, Obesity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Elevated levels of serum uric acid (SUA) are strongly associated with several components of the metabolic syndrome, particularly obesity. Previous studies have reported the correlation between SUA levels, xanthine oxidoreductase (XOR) activity, and the imbalanced adipokine levels that are characteristic of obesity. In this study, we explored the effect of febuxostat on circulating adipokine profiles in patients with overweight or obesity and asymptomatic hyperuricemia.

Methods

This study was a single-center, randomized, and controlled clinical trial that enrolled 130 participants with asymptomatic hyperuricemia and obesity. One hundred seventeen participants were included in the final analysis, with 60 participants in the febuxostat group and 57 in the control group. We compared the circulating adipokine levels at 3 and 6 months, including high molecular weight (HMW) adiponectin, chemerin, omentin, monocyte chemotactic protein-1, asprosin, fibroblast growth factor 21, neuregulin-4, leptin, resistin, vaspin, visfatin, adipsin, and assessed the correlation between changes in adipokine levels (Δadipokines) and changes in XOR activity (ΔXOR) after febuxostat treatment.

Results

The results showed that an increase in HMW adiponectin and omentin levels and a decrease in chemerin and asprosin levels at 3 or 6 months compared to the control group. Additionally, a positive correlation was observed between ΔXOR activity and Δasprosin. Furthermore, after adjusting for triglyceride (ΔTG) and serum uric acid (ΔSUA) in multiple linear regression analyses, we found that ΔXOR activity was independently correlated with Δasprosin.

Conclusion

This study may provide important evidence that febuxostat could alleviate the imbalance in circulating adipokine levels in patients with overweight or obesity and asymptomatic hyperuricemia. Furthermore, we observed a positive correlation between changes in asprosin levels and changes in XOR activity after febuxostat treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FebuxostatHyperuricemiaAdipokinesObesityOverweightUric AcidHumansMaleFemaleMiddle AgedAdultGout SuppressantsAdiponectinNicotinamide PhosphoribosyltransferaseAgedLeptin

Stichwörter der Autor:innen

AdipokinesFebuxostatHyperuricemiaObesityXanthine oxidoreductase

Substanzen

FebuxostatAdipokinesUric AcidGout SuppressantsAdiponectinNicotinamide PhosphoribosyltransferaseLeptin

Autor:innen und Institutionen

  • Department of Endocrinology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, China.
  • Department of Neurology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, China.

Zitieren

APA

Dong, M., Cui, Z., Liu, Y., Bu, Y., An, K., & Mao, L. (2024). Effects of Febuxostat Therapy on Circulating Adipokine Profiles in Patients with Overweight or Obesity and Asymptomatic Hyperuricemia: A Randomized Controlled Study. Obesity Facts. https://doi.org/10.1159/000540701

Vancouver

Dong M, Cui Z, Liu Y, Bu Y, An K, Mao L. Effects of Febuxostat Therapy on Circulating Adipokine Profiles in Patients with Overweight or Obesity and Asymptomatic Hyperuricemia: A Randomized Controlled Study. Obesity Facts. 2024. doi:10.1159/000540701

BibTeX
@article{Dong2024,
  author = {Dong, Meijuan and Cui, Zhaohui and Liu, Yuanyuan and Bu, Yanlong and An, Kun and Mao, Li},
  title = {Effects of Febuxostat Therapy on Circulating Adipokine Profiles in Patients with Overweight or Obesity and Asymptomatic Hyperuricemia: A Randomized Controlled Study},
  journal = {Obesity Facts},
  year = {2024},
  doi = {10.1159/000540701}
}
Kostenlos starten →